The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
The pharmacological landscape and therapeutic potential of serine hydrolases
Open accessAbstract
Serine hydrolases perform crucial roles in many biological processes, and several of these enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's disease and infectious diseases. Despite this, most of the human serine hydrolases (of which there are more than 200) remain poorly characterized with respect to their physiological substrates and functions, and the vast majority lack selective, in vivo-active inhibitors. Here, we review the current state of pharmacology for mammalian serine hydrolases, including marketed drugs, compounds that are under clinical investigation and selective inhibitors emerging from academic probe development efforts. We also highlight recent methodological advances that have accelerated the rate of inhibitor discovery and optimization for serine hydrolases, which we anticipate will aid in their biological characterization and, in some cases, therapeutic validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Exploring the new world of the genome with DNA microarrays
Brown, P. O., & Botstein, D. (1999) · Nature Genetics · doi:10.1038/4462 · Cited by 2,414
Mass Spectrometry and Protein Analysis
Domon, B., & Aebersold, R. (2006) · Science · doi:10.1126/science.1124619 · Cited by 2,181
Isolation and characterization
Turksen, K. (2006) · Humana Press eBooks · Cited by 2,146
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Self-citationThe resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684
Self-citationCarbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry
Cravatt, B. F., Wright, A. T., & Kozarich, J. W. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.124125 · Cited by 1,270
Self-citationTriggers, targets and treatments for thrombosis
Mackman, N. (2008) · Nature · doi:10.1038/nature06797 · Cited by 1,188
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Self-citationSuppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134
Activity-based protein profiling: The serine hydrolases
Liu, Y., Patricelli, M. P., & Cravatt, B. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14694 · Cited by 1,133
Self-citationAn Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Self-citationThe plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A. M., Selley, D. E., Parsons, L. H., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 934
Self-citationReduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2
Bonventre, J. V., Huang, Z., Taheri, M. R., O'Leary, E., Li, E., Moskowitz, M. A., & Sapirstein, A. (1997) · Nature · doi:10.1038/37635 · Cited by 845
Structural basis of substrate specificity in the serine proteases
Perona, J. J., & Craik, C. S. (1995) · Protein Science · doi:10.1002/pro.5560040301 · Cited by 837
Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 748
Proteomics: the first decade and beyond
Patterson, S. D., & Aebersold, R. H. (2003) · Nature Genetics · doi:10.1038/ng1106 · Cited by 745
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Nomura, D. K., Morrison, B. E., Blankman, J. L., Long, J. Z., Kinsey, S. G., Marcondes, M. C. G., Ward, A. M., Hahn, Y. K., Lichtman, A. H., Conti, B., et al. (2011) · Science · doi:10.1126/science.1209200 · Cited by 727
Self-citationNeurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724
The biological impact of mass-spectrometry-based proteomics
Cravatt, B. F., Simon, G. M., & Yates III, J. R. (2007) · Nature · doi:10.1038/nature06525 · Cited by 705
Self-citationTargeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654
Augeri, D. J., Robl, J. A., Betebenner, D. A., Magnin, D. R., Khanna, A., Robertson, J. G., Wang, A., Simpkins, L. M., Taunk, P., Huang, Q., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050261p · Cited by 624
Villhauer, E. B., Brinkman, J. A., Naderi, G. B., Burkey, B. F., Dunning, B. E., Prasad, K., Mangold, B. L., Russell, M. E., & Hughes, T. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030091l · Cited by 613
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
Das, S. K., Eder, S., Schauer, S., Diwoky, C., Temmel, H., Guertl, B., Gorkiewicz, G., Tamilarasan, K. P., Kumari, P., Trauner, M., et al. (2011) · Science · doi:10.1126/science.1198973 · Cited by 581
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores.
Zechner, R., Kienesberger, P. C., Haemmerle, G., Zimmermann, R., & Lass, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800031-jlr200 · Cited by 576
Scanlan, M. J., Raj, B. K., Calvo, B., Garin-Chesa, P., Sanz-Moncasi, M. P., Healey, J. H., Old, L. J., & Rettig, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5657 · Cited by 574
Mechanism-Based Profiling of Enzyme Families
Evans, M. J., & Cravatt, B. F. (2006) · Chemical Reviews · doi:10.1021/cr050288g · Cited by 564
Self-citationHuman Pancreatic Digestive Enzymes
Whitcomb, D. C., & Lowe, M. E. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9589-z · Cited by 539
Biological actions and therapeutic potential of the glucagon-like peptides
Drucker, D. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.31068 · Cited by 500
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002) · Science · doi:10.1126/science.1076535 · Cited by 490
Self-citationInhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
Holst, J. J., & Deacon, C. F. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1663 · Cited by 487
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
Hauel, N. H., Nar, H., Priepke, H., Ries, U., Stassen, J.-M., & Wienen, W. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0109513 · Cited by 457
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439
Self-citationRoehrig, S., Straub, A., Pohlmann, J., Lampe, T., Pernerstorfer, J., Schlemmer, K.-H., Reinemer, P., & Perzborn, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050101d · Cited by 436
The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease
Long, J. Z., & Cravatt, B. F. (2011) · Chemical Reviews · doi:10.1021/cr200075y · Cited by 425
Self-citationFunctional Interrogation of the Kinome Using Nucleotide Acyl Phosphates
Patricelli, M. P., Szardenings, A. K., Liyanage, M., Nomanbhoy, T. K., Wu, M., Weissig, H., Aban, A., Chun, D., Tanner, S., & Kozarich, J. W. (2007) · Biochemistry · doi:10.1021/bi062142x · Cited by 418
Edwards, A. M., Isserlin, R., Bader, G. D., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · Nature · doi:10.1038/470163a · Cited by 411
Feng, J., Zhang, Z., Wallace, M. B., Stafford, J. A., Kaldor, S. W., Kassel, D. B., Navre, M., Shi, L., Skene, R. J., Asakawa, T., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070104l · Cited by 405
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387
Self-citationWilensky, R. L., Shi, Y., Mohler, E. R., Hamamdzic, D., Burgert, M. E., Li, J., Postle, A., Fenning, R. S., Bollinger, J. G., Hoffman, B. E., et al. (2008) · Nature Medicine · doi:10.1038/nm.1870 · Cited by 387
Tethering: Fragment-Based Drug Discovery
Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385
Discovering potent and selective reversible inhibitors of enzymes in complex proteomes
Leung, D., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2003) · Nature Biotechnology · doi:10.1038/nbt826 · Cited by 385
Self-citationCholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 371
Profiling Serine Hydrolase Activities in Complex Proteomes
Kidd, D., Liu, Y., & Cravatt, B. F. (2001) · Biochemistry · doi:10.1021/bi002579j · Cited by 368
Self-citationONO-5046, a novel inhibitor of human neutrophil elastase
Kawabata, K., Suzuki, M., Sugitani, M., Imaki, K., Toda, M., & Miyamoto, T. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91862-7 · Cited by 359
Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness
Jessani, N., Liu, Y., Humphrey, M., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162187599 · Cited by 359
Self-citationMacphee, C. H., Moores, K., Boyd, H., Dhanak, D., Ife, R. J., Leach, C. A., Leake, D. S., Milliner, K. J., Patterson, R. A., Suckling, K. E., et al. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380479 · Cited by 359
Activity-based probes that target diverse cysteine protease families
Kato, D., Boatright, K. M., Berger, A. B., Nazif, T., Blum, G., Ryan, C., Chehade, K. A. H., Salvesen, G. S., & Bogyo, M. (2005) · Nature Chemical Biology · doi:10.1038/nchembio707 · Cited by 356
Covalent Modifiers: An Orthogonal Approach to Drug Design
Potashman, M. H., & Duggan, M. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8008597 · Cited by 346
Sugimoto, H., Iimura, Y., Yamanishi, Y., & Yamatsu, K. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00024a009 · Cited by 341
Activity-based protein profiling for biochemical pathway discovery in cancer
Nomura, D. K., Dix, M. M., & Cravatt, B. F. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2901 · Cited by 341
Self-citationWEIBEL, E. K., HADVARY, P., HOCHULI, E., KUPFER, E., & LENGSFELD, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1081 · Cited by 341
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity
Shi, Y., & Burn, P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1469 · Cited by 333
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330
Self-citationKienesberger, P. C., Oberer, M., Lass, A., & Zechner, R. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800082-jlr200 · Cited by 330
Bar-On, P., Millard, C. B., Harel, M., Dvir, H., Enz, A., Sussman, J. L., & Silman, I. (2002) · Biochemistry · doi:10.1021/bi020016x · Cited by 328
Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 328
Self-citationMass Spectral Analysis in Proteomics
Yates, J. R. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.111502.082538 · Cited by 326
Activity-based Proteomics of Enzyme Superfamilies: Serine Hydrolases as a Case Study
Simon, G. M., & Cravatt, B. F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.097600 · Cited by 325
Self-citationMulti-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Endothelial lipase is a major determinant of HDL level
Ishida, T., Choi, S., Kundu, R. K., Hirata, K.-I., Rubin, E. M., Cooper, A. D., & Quertermous, T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16306 · Cited by 306
Long, J. Z., Nomura, D. K., & Cravatt, B. F. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.009 · Cited by 303
Self-citationThe discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., & Misselwitz, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3185 · Cited by 297
Chemical Approaches for Functionally Probing the Proteome
Greenbaum, D., Baruch, A., Hayrapetian, L., Darula, Z., Burlingame, A., Medzihradszky, K. F., & Bogyo, M. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t100003-mcp200 · Cited by 291
Eckhardt, M., Langkopf, E., Mark, M., Tadayyon, M., Thomas, L., Nar, H., Pfrengle, W., Guth, B., Lotz, R., Sieger, P., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701280z · Cited by 284
Prolyl peptidases: a serine protease subfamily with high potential for drug discovery
Rosenblum, J. S., & Kozarich, J. W. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00084-x · Cited by 284
Hadváry, P., Sidler, W., Meister, W., Vetter, W., & Wolfer, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52203-1 · Cited by 280
Characterization of the lipolytic activity of endothelial lipase
McCoy, M. G., Sun, G.-S., Marchadier, D., Maugeais, C., Glick, J. M., & Rader, D. J. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30466-1 · Cited by 280
Bachovchin, D. A., Ji, T., Li, W., Simon, G. M., Blankman, J. L., Adibekian, A., Hoover, H., Niessen, S., & Cravatt, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011663107 · Cited by 274
Self-citationNomura, D. K., Lombardi, D. P., Chang, J. W., Niessen, S., Ward, A. M., Long, J. Z., Hoover, H. H., & Cravatt, B. F. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.05.009 · Cited by 270
Self-citationDisparate proteome reactivity profiles of carbon electrophiles
Weerapana, E., Simon, G. M., & Cravatt, B. F. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.91 · Cited by 246
Self-citationGut Peptides in the Regulation of Food Intake and Energy Homeostasis
Murphy, K. G., Dhillo, W. S., & Bloom, S. R. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0028 · Cited by 245
Bachovchin, D. A., Brown, S. J., Rosen, H., & Cravatt, B. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1531 · Cited by 245
Self-citationActivity-based probes for proteomic profiling of histone deacetylase complexes
Salisbury, C. M., & Cravatt, B. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608659104 · Cited by 243
Self-citationClick-generated triazole ureas as ultrapotent in vivo–active serine hydrolase inhibitors
Adibekian, A., Martin, B. R., Wang, C., Hsu, K.-L., Bachovchin, D. A., Niessen, S., Hoover, H., & Cravatt, B. F. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.579 · Cited by 243
Self-citationA streamlined platform for high-content functional proteomics of primary human specimens
Jessani, N., Niessen, S., Wei, B. Q., Nicolau, M., Humphrey, M., Ji, Y., Han, W., Noh, D.-Y., Yates, J. R., Jeffrey, S. S., et al. (2005) · Nature Methods · doi:10.1038/nmeth778 · Cited by 240
Self-citationThe human genome and drug discovery after a decade. Roads (still) not taken
Isserlin, R., Bader, G. D., Edwards, A. M., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1102.0448 · Cited by 232
DIALIGN-TX: greedy and progressive approaches for segment-based multiple sequence alignment
Subramanian, A. R., Kaufmann, M., & Morgenstern, B. (2008) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-3-6 · Cited by 229
Gastric Inhibitory Polypeptide: the neglected incretin revisited
Meier, J. J., Nauck, M. A., Schmidt, W. E., & Gallwitz, B. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00039-3 · Cited by 226
Cheng, J. D., Dunbrack, R. L., Valianou, M., Rogatko, A., Alpaugh, R. K., & Weiner, L. M. (2002) · PubMed · Cited by 217
Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity
Ahn, K., Johnson, D. S., Fitzgerald, L. R., Liimatta, M., Arendse, A., Stevenson, T., Lund, E. T., Nugent, R. A., Nomanbhoy, T. K., Alexander, J. P., et al. (2007) · Biochemistry · doi:10.1021/bi701378g · Cited by 216
Self-citationDabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin
Eisert, W. G., Hauel, N., Stangier, J., Wienen, W., Clemens, A., & van Ryn, J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.203604 · Cited by 216
Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo
Thomsen, T., & Kewitz, H. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90429-u · Cited by 207
Wilk, S. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90285-0 · Cited by 207
Adams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B., & Wallner, B. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0447 · Cited by 202
Chiang, K. P., Niessen, S., Saghatelian, A., & Cravatt, B. F. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.08.008 · Cited by 201
Self-citationDiscovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Johnson, D. S., Stiff, C., Lazerwith, S. E., Kesten, S. R., Fay, L. K., Morris, M., Beidler, D., Liimatta, M. B., Smith, S. E., Dudley, D. T., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100190t · Cited by 199
Self-citationFujikawa, K., Legaz, M. E., Kato, H., & Davie, E. W. (1974) · Biochemistry · doi:10.1021/bi00719a006 · Cited by 196
Brandstetter, H., Turk, D., Hoeffken, H. W., Grosse, D., Stürzebecher, J., Martin, P. D., Edwards, B. F. P., & Bode, W. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)91054-s · Cited by 195
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism
Eriksson, B. I., Quinlan, D. J., & Eikelboom, J. W. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-062209-095159 · Cited by 194
Ma, K., Cilingiroglu, M., Otvos, J. D., Ballantyne, C. M., Marian, A. J., & Chan, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438039100 · Cited by 189
Rettig, W. J., Garin‐Chesa, P., Healey, J. H., Su, S. L., Ozer, H. L., Schwab, M. G., Albino, A. P., & Old, L. J. (1993) · PubMed · Cited by 188
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
Naidu, P. S., Varvel, S. A., Ahn, K., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0689-4 · Cited by 184
Self-citationCarcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo
Jessani, N., Humphrey, M., McDonald, W. H., Niessen, S., Masuda, K., Gangadharan, B., Yates, J. R., Mueller, B. M., & Cravatt, B. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404727101 · Cited by 184
Self-citationSerine hydrolase targets of organophosphorus toxicants
Casida, J. E., & Quistad, G. B. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.036 · Cited by 183
Russo, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119941 · Cited by 182
A Functional Proteomic Strategy to Discover Inhibitors for Uncharacterized Hydrolases
Li, W., Blankman, J. L., & Cravatt, B. F. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073650c · Cited by 180
Self-citationHolmes, R. S., Wright, M. W., Laulederkind, S. J. F., Cox, L. A., Hosokawa, M., Imai, T., Ishibashi, S., Lehner, R., Miyazaki, M., Perkins, E. J., et al. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9284-4 · Cited by 180
Wei, E., Ben Ali, Y., Lyon, J., Wang, H., Nelson, R., Dolinsky, V. W., Dyck, J. R. B., Mitchell, G., Korbutt, G. S., & Lehner, R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.005 · Cited by 177
Cheng, C. L., Johnson, S. P., Keir, S. T., Quinn, J. A., Ali-Osman, F., Szabo, C., Li, H., Salzman, A. L., Dolan, M. E., Modrich, P., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0128 · Cited by 171
Llarrull, L. I., Testero, S. A., Fisher, J. F., & Mobashery, S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.008 · Cited by 170
The pharmacology of galanthamine and its analogues
Harvey, A. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02002-0 · Cited by 169
Flentke, G. R., Munoz, E., Huber, B. T., Plaut, A. G., Kettner, C. A., & Bachovchin, W. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1556 · Cited by 168
Justinova, Z., Mangieri, R. A., Bortolato, M., Chefer, S. I., Mukhin, A. G., Clapper, J. R., King, A. R., Redhi, G. H., Yasar, S., Piomelli, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.008 · Cited by 161
Cholinesterase inhibitors in the treatment of dementia.
Ellis, J. M. (2005) · PubMed · Cited by 161
Mahrus, S., & Craik, C. S. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.03.006 · Cited by 158
Hoover, H. S., Blankman, J. L., Niessen, S., & Cravatt, B. F. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.091 · Cited by 150
Self-citationLee, J., Chen, Y., Tolstykh, T., & Stock, J. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6043 · Cited by 142
Prolylcarboxypeptidase regulates food intake by inactivating α-MSH in rodents
Wallingford, N. M., Perroud, B., Gao, Q., Coppola, A. M., Gyengési, E., Liu, Z.-W., Gao, X., Diament, A. L., Haus, K. A., Shariat‐Madar, Z., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37209 · Cited by 141
Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation
Metzler, W. J., Yanchunas, J., Weigelt, C. A., Kish, K., Klei, H. E., Xie, D., Zhang, Y., Corbett, M. J., Tamura, J. K., He, B., et al. (2008) · Protein Science · doi:10.1110/ps.073253208 · Cited by 132
Hughes, T. E., Mone, M. D., Russell, M. E., Weldon, S. C., & Villhauer, E. B. (1999) · Biochemistry · doi:10.1021/bi990852f · Cited by 129
Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth
Cheng, J. D., Valianou, M., Canutescu, A. A., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0269 · Cited by 129
Blackie, J. A., Bloomer, J. C., Brown, M. J. B., Cheng, H., Hammond, B., Hickey, D. M. B., Ife, R. J., Leach, C. A., Lewis, V. A., Macphee, C. H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00058-1 · Cited by 128
Optimization of Activity-Based Probes for Proteomic Profiling of Histone Deacetylase Complexes
Salisbury, C. M., & Cravatt, B. F. (2008) · Journal of the American Chemical Society · doi:10.1021/ja074138u · Cited by 127
Self-citationLehner, R. S., & Vance, D. E. (1999) · Biochemical Journal · doi:10.1042/bj3430001 · Cited by 126
The rationale for E2020 as a potent acetylcholinesterase inhibitor
Kawakami, Y., Inoue, A., Kawai, T., Wakita, M., Sugimoto, H., & Hopfinger, A. J. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(96)00137-x · Cited by 126
Shin, S., Lee, T., Ha, N., Koo, H. M., Kim, S., Lee, H., Kim, Y. S., & Oh, B. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2509 · Cited by 124
Triacylglycerol hydrolase: role in intracellular lipid metabolism
Dolinsky, V. W., Gilham, D., Alam, M., Vance, D. E., & Lehner, R. S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3426-3 · Cited by 123
Villhauer, E. B., Brinkman, J. A., Naderi, G. B., Dunning, B. E., Mangold, B. L. K., Mone, M. D., Russell, M. E., Weldon, S. C., & Hughes, T. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025522z · Cited by 122
JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.
Toide, K., Iwamoto, Y., Fujiwara, T., & Abe, H. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10670-8 · Cited by 118
Edosada, C. Y., Quan, C. L., Wiesmann, C., Tran, T., Sutherlin, D., Reynolds, M., Elliott, J. M., Raab, H. E., Fairbrother, W. J., & Wolf, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511112200 · Cited by 114
Purification and Characterization of a Porcine Liver Microsomal Triacylglycerol Hydrolase
Lehner, R. S., & Verger, R. (1997) · Biochemistry · doi:10.1021/bi962186d · Cited by 114
Wood, W. J. L., Patterson, A. W., Tsuruoka, H., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0547230 · Cited by 114
Damblon, C., Raquet, X., Lian, L., Lamotte‐Brasseur, J., Fonzé, E., Charlier, P., Roberts, G. C. K., & Frère, J.-M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1747 · Cited by 114
Gilham, D., Ho, S. B., Rasouli, M., Martres, P., Vance, D. E., & Lehner, R. S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0728fje · Cited by 114
Bachovchin, D. A., Mohr, J. T., Speers, A. E., Wang, C., Berlin, J. M., Spicer, T., Fernández-Vega, V., Chase, P. S., Hodder, P., Schürer, S. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015248108 · Cited by 110
Self-citationMorain, P., Lestage, P. J., Nanteuil, G. D., Jochemsen, R., Robin, J., Guez, D., & Boyer, P. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00214.x · Cited by 108
Davis, B., Koster, G., Douet, L., Ščigelová, M., Woffendin, G., Ward, J. M., Smith, A., Humphries, J., Burnand, K. G., Macphee, C. H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m709970200 · Cited by 105
Magnin, D. R., Robl, J. A., Sulsky, R. B., Augeri, D. J., Huang, Y., Simpkins, L. M., Taunk, P. C., Betebenner, D. A., Robertson, J. G., Abboa‐Offei, B. E., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049924d · Cited by 105
A Potent and Selective Inhibitor of KIAA1363/AADACL1 that Impairs Prostate Cancer Pathogenesis
Chang, J. W., Nomura, D. K., & Cravatt, B. F. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.02.008 · Cited by 103
Self-citationDiversity of Serine Hydrolase Activities of Unchallenged and Botrytis-infected Arabidopsis thaliana
Kaschani, F., Gu, C., Niessen, S., Hoover, H. S., Cravatt, B. F., & van der Hoorn, R. A. L. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800494-mcp200 · Cited by 101
Self-citationDiscovering Disease-Associated Enzymes by Proteome Reactivity Profiling
Barglow, K. T., & Cravatt, B. F. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.023 · Cited by 99
Self-citationPuustinen, P., Junttila, M. R., Vanhatupa, S., Sablina, A. A., Hector-Greene, M., Teittinen, K. J., Raheem, O., Ketola, K., Lin, S., Kast, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2760 · Cited by 98
Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine
Hagel, M., Niu, D., St Martin, T., Sheets, M. P., Qiao, L., Bernard, H., Karp, R. M., Zhu, Z., Labenski, M. T., Chaturvedi, P., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.492 · Cited by 95
Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs
Bongers, J., LAMBROS, T. J., Ahmad, M., & Heimer, E. P. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90317-7 · Cited by 94
Patterson, A. W., Wood, W. J. L., Hornsby, M. J., Lesley, S. A., Spraggon, G., & Ellman, J. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060701s · Cited by 92
A fluopol-ABPP HTS assay to identify PAD inhibitors
Knuckley, B., Jones, J. E., Bachovchin, D. A., Slack, J. L., Causey, C. P., Brown, S. J., Rosen, H., Cravatt, B. F., & Thompson, P. R. (2010) · Chemical Communications · doi:10.1039/c0cc02634d · Cited by 92
Self-citationThe therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
Levy, J. H., & O’Donnell, P. S. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.9.1077 · Cited by 87
NOCHI, S., ASAKAWA, N., & Sato, T. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.1145 · Cited by 85
Oefner, C., D'Arcy, A., Sweeney, A. M., et al. (2003) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903010059 · Cited by 83
XLII.—Physostigmine (eserine). Part III
Stedman, E., & Barger, G. (1925) · Journal of the Chemical Society Transactions · doi:10.1039/ct9252700247 · Cited by 83
RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia
Shields, D. J., Niessen, S., Murphy, E. A., Mielgo, A., Desgrosellier, J. S., Lau, S. K. M., Barnes, L. A., Lesperance, J., Bouvet, M., Tarin, D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911646107 · Cited by 77
Self-citationDiscovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors
Xu, J., Ok, H., Gonzalez, E. J., Colwell, L. F., Habulihaz, B., He, H., Leiting, B., Lyons, K. A., Marsilio, F., Patel, R. A., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.099 · Cited by 77
Schneider, J., Giardiniere, M., & Morain, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00307-4 · Cited by 75
Preferential Cerebrospinal Fluid Acetylcholinesterase Inhibition by Rivastigmine in Humans
Kennedy, J. S., Polinsky, R. J., Johnson, B. W., Loosen, P. T., Enz, A., Laplanche, R., Schmidt, D. E., Mancione, L., Parris, W. C. V., & Ebert, M. H. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199912000-00005 · Cited by 74
Bachovchin, D. A., Zuhl, A. M., Speers, A. E., Wolfe, M. R., Weerapana, E., Brown, S. J., Rosen, H., & Cravatt, B. F. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200502u · Cited by 74
Self-citationDevelopment of activity-based probes for trypsin-family serine proteases
Pan, Z., Jeffery, D. A., Chehade, K. A. H., Beltman, J., Clark, J. M., Grothaus, P. G., Bogyo, M. S., & Baruch, A. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.012 · Cited by 74
Glucagon-like peptide-1 and control of insulin secretion.
Thorens, B. (1995) · PubMed · Cited by 72
Genomic overview of serine proteases
Yousef, G. M., Kopolovic, A. D., Elliott, M. B., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00638-7 · Cited by 67
Engineering of a macromolecular scaffold to develop specific protease inhibitors
Stoop, A. A., & Craik, C. S. (2003) · Nature Biotechnology · doi:10.1038/nbt860 · Cited by 63
A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability
Woitach, J. T., Zhang, M., Niu, C., & Thorgeirsson, S. S. (1998) · Nature Genetics · doi:10.1038/1258 · Cited by 62
S 17092-1, a Highly Potent, Specific and Cell Permeant Inhibitor of Human Proline Endopeptidase
Barelli, H., Petit-Paitel, A., Hirsch, É. C., Wilk, S., Nanteuil, G. D., Morain, P., & Checler, F. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0366 · Cited by 62
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans
Thomsen, T., Bickel, U., Fischer, J. P., & Kewitz, H. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316106 · Cited by 62
Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal
Bakker, A. V., Jung, S., Spencer, R. W., Vinick, F. J., & Faraci, W. S. (1990) · Biochemical Journal · doi:10.1042/bj2710559 · Cited by 59
Bellemère, G., Morain, P., Vaudry, H., & Jégou, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01536.x · Cited by 59
Sontag, J., Nunbhakdi‐Craig, V., Mitterhuber, M., Ogris, E., & Sontag, E. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07049.x · Cited by 57
Recent Advances in Targeting Viral Proteases for the Discovery of Novel Antivirals
Steuber, H., & Hilgenfeld, R. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790725470 · Cited by 57
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors
Goodman, K. B., Bury, M. J., Cheung, M., Cichy-Knight, M. A., Dowdell, S. E., Dunn, A. K., Lee, D. M., Lieby, J. A., Moore, M. L., Scherzer, D. A., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.033 · Cited by 53
Madsen, M. A., Deryugina, E. I., Niessen, S., Cravatt, B. F., & Quigley, J. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601223200 · Cited by 53
Self-citationAminoacylpyrrolidine-2-nitriles: Potent and Stable Inhibitors of Dipeptidyl-Peptidase IV (CD 26)
Li, J., Wilk, E. K., & Wilk, S. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.0020 · Cited by 52
Edwards, P. D., Zottola, M. A., Davis, M. W., Williams, J. C., & Tuthill, P. A. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00020a011 · Cited by 51
White, M. J., Savaryn, J. P., Bretl, D. J., He, H., Penoske, R. M., Terhune, S. S., & Zahrt, T. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018175 · Cited by 50
Toide, K., Fujiwara, T., Iwamoto, Y., Shinoda, M., Okamiya, K., & Kato, T. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168640 · Cited by 47
Peptidomics of Prolyl Endopeptidase in the Central Nervous System
Nolte, W. M., Tagore, D. M., Lane, W. S., & Saghatelian, A. (2009) · Biochemistry · doi:10.1021/bi901637c · Cited by 43
Dale, P. (1995) · Land Use Policy · doi:10.1016/0264-8377(95)90037-3 · Cited by 42
Inhibitors of Tissue Factor • Factor VIIa for Anticoagulant Therapy
Lazarus, R. A., Olivero, A. G., Eigenbrot, C. W., & Kirchhofer, D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364568 · Cited by 42
Tew, D. G., Boyd, H., Ashman, S. M., Theobald, C. J., & Leach, C. A. (1998) · Biochemistry · doi:10.1021/bi9801412 · Cited by 41
Nakayama, Y., Odagaki, Y., Fujita, S., Matsuoka, S., Hamanaka, N., Nakai, H., & Toda, M. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00393-1 · Cited by 38
Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV
Lambeir, A. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(96)00012-8 · Cited by 37
Becker, S., Simpson, J. C., Pepperkok, R., Heinz, S., Herder, C., Grez, M., Seifried, E., & Tonn, T. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-06-0360 · Cited by 35
On The Edge of Validation – Cancer Protease Fibroblast Activation Protein
Wolf, B. B., Quan, C. L., Tran, T., Wiesmann, C., & Sutherlin, D. P. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708784567449 · Cited by 34
Bachovchin, D. A., Wolfe, M. R., Masuda, K. R., Brown, S. J., Spicer, T., Fernández-Vega, V., Chase, P. S., Hodder, P., Rosen, H., & Cravatt, B. F. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.011 · Cited by 33
Self-citationLópez, A., Tarragó, T., & Giralt, E. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.577416 · Cited by 33
Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
Zalewski, A., Macphee, C. H., & Nelson, J. A. (2005) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/156800605774962103 · Cited by 31
Fatty Acid Amide Hydrolase Inhibitors – Progress and Potential
Khanna, I., & Alexander, C. W. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711796234989 · Cited by 27
Morak, M., Schmidinger, H., Krempl, P. M., Rechberger, G. N., Kollroser, M., Birner‐Gruenberger, R., & Hermetter, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800566-jlr200 · Cited by 23
Cited by
BODIPY-based probes for the fluorescence imaging of biomolecules in living cells
Kowada, T., Maeda, H., & Kikuchi, K. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00030k · Cited by 1,381
Gehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
Targeted Covalent Inhibitors for Drug Design
Baillie, T. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601091 · Cited by 578
Global profiling of lysine reactivity and ligandability in the human proteome
Hacker, S. M., Backus, K. M., Lazear, M. R., Forli, S., Correia, B. E., & Cravatt, B. F. (2017) · Nature Chemistry · doi:10.1038/nchem.2826 · Cited by 485
Self-citationEnzyme Inhibitor Discovery by Activity-Based Protein Profiling
Niphakis, M. J., & Cravatt, B. F. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035708 · Cited by 366
Self-citation
Metadata
- Authors
- Bachovchin, D. A., & Cravatt, B. F.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-01
- Volume
- 11
- Issue
- 1
- Pages
- 52-68
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2005008585
- Cited by
- 308
- References
- 193
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.